Tag | Content |
---|
EnhancerAtlas ID | HS187-19760 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr5:95171200-95173100 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr5:95172381-95172402 | AAGCTGAAACTGAAAGGTAAA | - | 6.55 | Nr2f6(var.2) | MA0728.1 | chr5:95172834-95172849 | GAGGTCATGAGTTCA | + | 6.26 | RARA | MA0729.1 | chr5:95172834-95172852 | GAGGTCATGAGTTCAAGA | + | 6.12 |
|
| Number of super-enhancer constituents: 28 | ID | Coordinate | Tissue/cell |
SE_00235 | chr5:95169503-95173191 | Adipose_Nuclei | SE_03791 | chr5:95171345-95171945 | Brain_Angular_Gyrus | SE_06654 | chr5:95169811-95172253 | Brain_Hippocampus_Middle | SE_09663 | chr5:95167874-95173176 | CD14 | SE_11777 | chr5:95169040-95174162 | CD20 | SE_12316 | chr5:95170218-95172777 | CD3 | SE_18767 | chr5:95169488-95172977 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19610 | chr5:95169977-95172569 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20485 | chr5:95169651-95172656 | CD56 | SE_24621 | chr5:95171410-95171746 | Colon_Crypt_2 | SE_25672 | chr5:95169342-95172923 | DND41 | SE_26405 | chr5:95169506-95172780 | Duodenum_Smooth_Muscle | SE_27962 | chr5:95169569-95172001 | Fetal_Intestine | SE_28976 | chr5:95169454-95171682 | Fetal_Intestine_Large | SE_31877 | chr5:95171256-95172017 | Gastric | SE_34665 | chr5:95169687-95172810 | HeLa | SE_37859 | chr5:95169681-95173147 | HSMMtube | SE_40949 | chr5:95171173-95172010 | Left_Ventricle | SE_42421 | chr5:95171167-95172444 | Lung | SE_48283 | chr5:95170216-95173158 | Psoas_Muscle | SE_48806 | chr5:95171240-95172026 | Right_Atrium | SE_50448 | chr5:95171223-95172085 | Sigmoid_Colon | SE_52585 | chr5:95171119-95172025 | Small_Intestine | SE_53861 | chr5:95171242-95172029 | Spleen | SE_53861 | chr5:95172050-95172712 | Spleen | SE_55361 | chr5:95171320-95171770 | Thymus | SE_56476 | chr5:95169568-95172918 | u87 | SE_62882 | chr5:95143144-95179855 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AATATTTACC ATATGCACTT TCACTTGTAT GTTTAATCTT TTTATTTATT TAAAGTAGGT 60 ACTGGGATGT AGGGAGTTGG AGAAACCCGT TTGGACTAGA CTTTAAAGAA CTGTGGCAGA 120 AGGGTATGAG ATACAATAAC AGCTTGAGGG AATAGCAGGA TTGAGAAAAA GCATCTTTCA 180 TTTAAGGGAA ACTCGACTAT GTTTGTTTTA TTTTTTTCCT TTTGCAGAGA GGAAGCAACT 240 AGTTGAGGGG GGAGAATATG AGAGAGAGAG ACAGAGAGAG AGAAAGACGA TGCTTGATGG 300 AGCAAAGTCA CCAACAGCAC TGGAGGAGGG GACAGAGGGC CAGGCAGTGG GGCTGACCTC 360 AGAGAAGAGG GGTGCACCTT TGGAGGGTGC ACCGGGAAGG GAGGGGACAA ACAAGGAGGG 420 TGCCGAGGCT GAGGATGGGC AAGCTAACTG GCCACAGTGC AAGCCCAAGG GGACGAGGGA 480 TTCCAGACTC TGGACACACG GCCGAAATAG CCAACTGTGG GCTCCTGGCT ACAGAGGAGG 540 TGAGTGGAGC CAGGAGAAGA AGATGAGAGA AGAGAATGGA GAGGCATTAA GTCAAGATGA 600 AGAATAAAAA CTGGTTCAGT GCCAGGGTTT AAAAAAACAA TAATATTTTT AAAACGTTAT 660 GCCCAGTGAC AGGAAATTCA GGCTCTGGGT GACAGGAAAT TCAGTAGGCA CTCGGTGGCT 720 GCTGGGCTGC ATGACTCAAT TTGTGTAGCA ATGTCGAATG CTGAAACAAA AAATAAAAGT 780 TTTTTAAAAA ATACTTTCAA GGTTTTGGGA AATATAATTT TGGTTAACAT GACCCCACAA 840 TTAAATGAGG TCTATTTAAT TAGGGAGGCA GTACTTCTGG AGGAAAACAA ATTGCCTAGG 900 CTGTCAATTT AGCAATGCAA CAAAACATGA AATCAATAGT TTATTAATAT CAGGTGTATG 960 GGTATACACC TGCCTTATAC AGAAGTAAGA GCTGTATTCA CACACCTAGT TGCAAAGAAA 1020 TTAAACATGA GCTGAGATGC TCAAAGAAAA TGAATCACTT AGGGATAGAG CATCTCTAAT 1080 TCGAAAGGAC AGTTTGTCCC ACCCAGAAAC AATCTCTGGG CTCATGTGTA GATGGAACTG 1140 TCACTTGGAA TGACTTGTCA AAAGGGCTTC AGGTAAAACT AAAGCTGAAA CTGAAAGGTA 1200 AAACTCTGAG CTAATAATAA CTATTGACCC ACATCACCAG AAAGTTTTGG AAATGAATCA 1260 AGAGGAAACA ACAGCCACTT AGCCCTTCCT CACCCAAGAA TCCTCTCTGC CATTCCTTTC 1320 CATCCAGCAC TTTTTCCCTG TGTAATAACT TTTGGCTCTC ATATTTCATT ACTCCTCCAC 1380 AGAATATGAG GTTCAATTAC AGGACTCTCA CACAGATAGA TGACAAGTGT ACTTGTGACA 1440 AAATGTTCTC TAGTGGGCTT CTGGCTAATA TATTTTTGGC ACATCCAAAT TATGAAAGAG 1500 GACACAATTG TTGGTAAAAC CAAGGAAGGC ATGTATGTGC TGAGTATTCT GTGTCTAAAA 1560 TCAAAGTAGG CTGGGCACAG TGGCTCACGC CTGTAATCCC AGCACTTTGG GGGACCGAGG 1620 TGGGTGGATC ATTTGAGGTC ATGAGTTCAA GATCAGCCTG GCCAACATGG TGAAACCCCA 1680 TCTCTACTAA AAACACAAAA CTTAGCTGGG TATGGTGGCA TGTGCCTGTA ATCCCAGCTA 1740 CTTGGGAGGC TGAGGCAAGA GAATCGCTTG AATCCAGGAG GTGTAGGTTA CAGTGAACTG 1800 AGATCACAGC ACTGCACTCC AGCCTGGGCG ATACAGTGAG ACTCCATCTC AAAAAAAAAC 1860 CCCAAAAAAC AACAAAAAAA ACAAAAAAAC ACAAAACCAC 1900
|